DNA repair polymorphisms in B-cell chronic lymphocytic leukemia in sufferers of chernobyl nuclear power plant accident

Journal of Radiation Research

Volumn 53, Issue 3, 2012, Pages 497-503

  Abramenko, Iryna ^a   Bilous, Nadiia ^a   Chumak, Anatolyi ^a   Kostin, Alexey ^a   Martina, Zoya ^a   Dyagil, Iryna ^a  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

Author keywords

Chernobyl NPP accident; CLL; DNA repair; Ionizing radiation; Polymorphism

Indexed keywords

DISEASES; DNA; GENES; NUCLEAR ENERGY; NUCLEAR FUELS; NUCLEAR POWER PLANTS; NUCLEAR REACTOR ACCIDENTS; POLYMERASE CHAIN REACTION; RADIATION SHIELDING; REPAIR;

B CELL CHRONIC LYMPHOCYTIC LEUKEMIA; CHERNOBYL; CHERNOBYL NUCLEAR POWER PLANT ACCIDENT; CHRONIC LYMPHOCYTIC LEUKEMIAS; DNA-REPAIR; ENVIRONMENTAL DEVELOPMENT; ENVIRONMENTAL FACTORS; GENE POLYMORPHISM; NUCLEAR POWER PLANT ACCIDENT; WORKERS';

IONIZING RADIATION;

EID: 84863496546     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.11093     Document Type: Review

References (53)

1. Fedorenko Z, et al (2009) Cancer in Ukraine, 2007-2008, Bulletin of National cancer-registry of Ukraine, Vol. 10, National Cancer Institute of Ukraine, Kiev.
2. Jemal A, et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
3. Hamblin T (2008) Have we been wrong about ionizing radiation and chronic lymphocytic leukemia. Leuk Res 32: 523-525.
4. Richardson D, et al (2005) Ionizing radiation and chronic lymphocytic leukemia. Environ Health Perspect 113: 1-5.
5. Samson E, et al (2011) Cancer mortality among two different populations of French nuclear workers. Int Arch Occup Environ Health 84; 627-634.
6. Boice J, et al (2011) Updated mortality analysis of radiation workers at Rocketdyne (atomic international), 1948-2008. Radiat Res 176: 244-258.
7. Krestinina L, et al (2010) Leukemia incidence among People exposed to chronic radiation from the contaminated Techa River, 1953-2005. Radiat Environ Biohys 49: 195-201.
8. Kesminiene A, et al (2008) Risk of hematological malignancies among Chernobyl liquidators. Radiat Res 170: 721-735.
9. Gluzman D, et al (2011) Mature B-CELL neoplasms in Chernobyl clean-up workers of 1986-1987: summary of cytomorphological and immunocytochemical study in 25 years after Chernobyl accident. Exp Oncol 33: 47-51.
10. Romanenko A, et al (2008) The Ukrainian-American study of leukemia and related disorders among Chernobyl cleanup workers from Ukraine: III. Radiation risks. Radiat Res 170: 711-720.
11. Kryachok I, et al (2005) Comparative analysis of CLL in persons who suffered after Chernobyl accident and in unexposed CLL patients. Haematologica 90 (Suppl.): 454a.
12. Polyshchuk O (2005) Clinical and hematological features and the approaches to treatment of chronic lymphocytic leukemia in clean-up workers of Chernobyl NPP accident 1986-1987. Thesis for a degree of Candidate of Medical Science, p. 20, Kiev.
13. Abramenko I, et al (2008) Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident-with focus on immunoglobulin heavy chain gene analysis. Leuk Res 32: 535-545.
14. Li C, et al (2010) Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors. Cancer Res 70: 7187-7198.
15. Veremeyeva G, et al (2010) A new approach to individual prognostication of cancer development under conditions of chronic radiation exposure. Int J Low Rad 7: 53-80.
16. Jeggo P and Lobrich M (2006) Radiation-induced DNA damage responses. Radiat Prot Dosimetry 122: 124-127.
17. Wood KD, et al (2001) Human DNA repair genes. Science 291: 1284-1289.
18. Vodicka P, et al (2007) Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 28: 657-664.
19. Hung RJ, et al (2005) Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162: 925-942.
20. Hong Y, et al (2005) Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer. Int J Cancer 116: 428-432.
21. Kiran M, et al (2009) Polymorphism of DNA repair gene XRCCl and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol. Cell Biochem 327: 7-13.
22. Romanowicz H, et al (2010) Genetics polymorphism in DNA repair genes by base excision repair pathway (XRCCl) and homologous recombination (XRCC2 and RAD51) and die risk of breast carcinoma in the Polish population. Pol J Pathol 61: 206-216.
23. Andreassi MG, et al (2009) Genetic polymorphisms in XRCCl, OGGI, APEl and XRCC3 DNA repair genes, ionizing radiation exposure and chromosomal DNA damage in interventional cardiologists. Mutat Res 666: 57-63.
24. Cho Y, et al (2009) Micronucleus-centromere assay and DNA repair gene polymorphism in lymphocytes of industrial radiographers. Mutat Res 680: 17-24.
25. Krupa R, et al (2011) Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer-a case control study. Mol Biol Rep 38: 2849-2854.
26. Peluso M, et al (2010) Smoking, DNA adducts and number of risk DNA repair alleles in lung cancer cases, in subjects with benign lung diseases and in controls. J Nucleic Acids 2010: 386798.
27. Narter KF, et al (2009) Bladder cancer and polymorphisms of DNA repair genes (XRCCl, XRCC3, XPD, XPG, APEl, hOGGl. Anticancer Res 29: 1389-1393.
28. Matullo G, et al (2001) XRCCl, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22: 1437-1445.
29. Huang C, et al (2011) Polymorphisms of COMT and XPD and risk of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. Biomarkers 16: 37-41.
30. Long X, et al (2009) XPD codon 312 and 751 polymorphisms, and A re 1 exposure, and hepatocellular carcinoma risk. BMC Cancer 9: 400.
31. Mechanic LE, et al (2005) Polymorphisms in XPD and TP53 and mutation in human lung cancer. Carcinogenesis 26: 597-604.
32. Gao W, et al (2010) Genetic polymorphisms in the DNA repair genes XPD and XRCCl, p53 gene mutations and bladder cancer risk. Oncol Rep 24: 257-262.
33. Rajaraman P, et al (2008) Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists. Int J Cancer 123: 2713-2716.
34. Ganster C, et al (2009) DNA repair polymorphisms associated with cytogenetic subgroups in B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 48: 760-767.
35. Rai KR, et al (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46: 219-234.
36. Binet JL, et al (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariante survival analysis. Cancer 48: 198-205.
37. Cheson ED, et al (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87: 4990-4997.
38. Hallek M, et al (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111: 5446-5456.
39. Romanenko A, et al (2008) The Ukrainian-American study of leukemia and related disorders among Chernobyl cleanup workers from Ukraine: I. Study methods. Radiat Res 170: 691-697.
40. Likhtarev IA, Chumak VV and Repin VS (1994) Retrospective reconstruction of individual and collective external gamma doses of population evacuated after the Chernobyl accident. Health Phys 66: 643-652.
41. Guskova AK and Baisogolov CD (1971) Luchevaya bolesn' cheloveka (Radiation Syndrome in Man). Moscow, Medicine, p. 384.
42. Seedhouse C, et al (2002) The genotype distribution of the XRCCl gene indicates a role for base excision repair in the development of therapy-related acute myeloid leukemia. Blood 100: 3731-3766.
43. Ozasa K, et al (2011) Risk of cancer and non-cancer diseases in the atomic bomb survivors. Radiat Prot Dosimetry 146: 272-275.
44. Vrijheid M, et al (2008) Ionizing radiation and risk of chronic lymphocytic leukemia in the 15-country study of nuclear industry workers. Radiat Res 170: 661-665.
45. Weiss HA, Darby SC and Doll R (1994) Cancer mortality following X-rays treatment for ankylosing spondylitis. Int J Cancer 59: 327-338.
46. Inskip PD, et al (1993) Leukemia, lymphoma, and multiple myeloma after pelvix radiotherapy for benign disease. Radiat Res 135: 108-124.
47. Matullo G, et al (2001) DNA repair gene polymorphisms, bulky adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 92: 562-567.
48. David-Beabes GL, Lunn RM and London SJ (2001) No association between the XPD (Lys75IGln) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 10: 911-912.
49. Hou SM, et al (2002) The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 23: 599-603.
50. Gribben JG (2008) Molecular profiling in CLL. In: Gewirts AM, Muchmore EA and Bums LI eds. Hematology 2008, the American Society Education Program Book. pp. 444-449. The American Society of Hematology; Washington DC.
51. Rossi D and Gaidano G (2009) Richter syndrome: molecular insights and clinical perspectives. Hematol Oncol 27: 1-10.
52. Fulop Z, et al (2003) Microsatellite instability and hMLHl promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia. Leukemia 17: 411-415.
53. Kuptsova N, et al (2007) Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood 109: 3936-3944.